A clinical trial on scabies skin infection

A pilot study on Mookiratai ennai(internal)and Avuri ennui(external)for the treatment of Sirangu(Scabies)

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/012225

Enrollment

Registered

2018-02-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Skin lesions in hands and interdigital spaces,itching worsen at night

Interventions

Intervention1: Mookiratai ennai internal,Avuri ennai external: 5ml o.d for 7 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.Lesions in the hands and interdigital spaces 2.Itching at night time 3.Mite tunnels 4.Rashes and sores 5.willing to sign informed consent

Exclusion criteria

Exclusion criteria: 1.past h/o any systemic diseases 2.Immune compromised patients 3.pustular lesions other than scabies 4.not willing for skin scrapping test

Design outcomes

Primary

Measure	Time frame
Reduction in the lesions and itchingTimepoint: 3 days after medication	—

Secondary

Measure	Time frame
Reduction in the formation of new lesionsTimepoint: 30 days after medication	—

Countries

India

Contacts

Public ContactVMahalakshmi

National institute of siddha

dramalaaruldhas@gmail.com9940429202

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026